About
Named for a balance of forces.
V(r) = 4ε [ (σ/r)12 − (σ/r)6 ]
The Lennard-Jones potential, introduced by physicist John Lennard-Jones in 1924, describes how two neutral molecules interact: a gentle attraction at a distance and a strong repulsion up close. Between them sits a point of stable equilibrium.
Chemistry is the common thread. From the compounds inside a seed to the molecules that shape how we age, our companies work where chemistry meets biology — using data and AI to understand how molecules interact with living systems, and turning that understanding into real products.
Lennard-Jones Holdings is built on the same principle. Our companies stay independent, each with its own team and focus, while drawing on shared capital, governance, and scientific insight. We hold them close enough to compound together, but never so close that they lose their edge.
Holdings
Four verticals
- IVisit →
Botanical Drug Discovery
Standard Seed Corporation
Evidence-based AI for regulated therapeutic products — mapping the chemistry of plants to guide botanical compounds from seed to medical market.
- IIVisit →
Cannabis Genomics
CannaMatrix
Patented genetic testing and AI predictive modeling that help growers and breeders select the best plants from their seed stock and create new strains faster.
- IIIVisit →
Canine Longevity
Blu Dog Longevity
A consumer analytics and tracking platform for canine healthspan, turning real-world data into insight on what helps dogs live healthier, longer lives.
- IVIn stealth
Capital
Private Fund
A private hedge fund currently operating in stealth. Further details will be shared in due course.
Performance
Operating companiesFigures shown are illustrative. The private fund is excluded while in stealth.